PCBP1

Across TCGA pan-cancer cohorts, PCBP1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated PCBP1 data layer compared with 24 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in brain lower grade glioma (LGG), where higher PCBP1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PCBP1 expression acts as an unfavorable survival marker.

LGG, HNSC, and COAD are the cancer types where PCBP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Median	All	0.216	0.738	.012	6	view →
HNSC	DFS	Median	All	0.138	0.626	.005	6	view →
COAD	OS	Median	IV	0.045	0.659	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PCBP1–LGG (DFS)

Open the LGG breakdown →